`
`
`
`NOT FOR PUBLICATION
`
`
`UNITED STATES DISTRICT COURT
`DISTRICT OF NEW JERSEY
`
`
`
`
` Civil Action No. 13-0391 (ES) (JAD)
`
` ORDER
`
`
`JAZZ PHARMACEUTICALS, INC.,
`et al.,
`
`
`Plaintiffs,
`
`v.
`
`
`AMNEAL PHARMACEUTICALS
`LLC, et al.,
`
`
`Defendants.
`
`
`SALAS, DISTRICT JUDGE
`
`
`
`
`WHEREAS presently pending before the Court is a motion for judgment on the pleadings
`
`as to U.S. Patent No. 8,772,306 (the “’306 patent”) filed by Defendant Par Pharmaceutical, Inc.
`
`(“Par”) pursuant to Federal Rule of Civil Procedure 12(c) (D.E. No. 244);
`
`WHEREAS matters outside the pleadings have been presented to the Court in conjunction
`
`with the pending motion for judgment on the pleadings, namely communications to and from the
`
`U.S. Food and Drug Administration (see D.E. No. 280-1, Exhs. 2-4), which appear critical to the
`
`Court’s resolution of the pending motion;
`
`WHEREAS the Federal Circuit has determined that a district court is entitled to examine
`
`documents “integral to or explicitly relied upon in the complaint” in evaluating a Rule 12(c) motion
`
`and, in particular, may examine “ANDA filings, Section viii statements, and proposed labeling”
`
`where a patentee’s complaint in an ANDA case “referenced and relied on [an ANDA filer’s] FDA
`
`filings, and the parties do not dispute the authenticity of the documents that are before the court,”
`
`
`
`1
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 327 Filed 11/14/16 Page 2 of 2 PageID: 6699
`
`see AstraZeneca Pharm. LP v. Apotex Corp., 669 F.3d 1370, 1378 n.5 (Fed. Cir. 2012) (citing In
`
`re Burlington Coat Factory Sec. Litig., 114 F.3d 1410, 1426 (3d Cir. 1997));
`
`WHEREAS the Court is concerned, however, that communications to and from the U.S.
`
`Food and Drug Administration do not plainly appear to fall within the ambit of what the Court
`
`may consider at this stage under AstraZeneca Pharm. LP v. Apotex Corp., 669 F.3d 1370, 1378
`
`n.5 (Fed. Cir. 2012) and In re Burlington Coat Factory Sec. Litig., 114 F.3d 1410, 1426 (3d Cir.
`
`1997);
`
`WHEREAS the Court, in its discretion, has accordingly elected to administratively
`
`terminate the instant motion for judgment on the pleadings and to grant Par leave to file a motion
`
`for summary judgment concerning the ’306 patent at a time it considers appropriate;
`
`IT IS on this 14th day of November 2016,
`
`ORDERED that Par’s motion pursuant to Federal Rule of Civil Procedure 12(c) (D.E. No.
`
`244) is administratively terminated; and it is further
`
`ORDERED that Par may file a motion for summary judgment pursuant to Federal Rule of
`
`Civil Procedure 56 when it sees fit; and it is further
`
`ORDERED that the Clerk of the Court shall terminate docket entry number 244.
`
`s/Esther Salas
`Esther Salas, U.S.D.J.
`
`2
`
`